Yahoo · Nov 2, 2026
LifeStance Health Flirts With Latest Buy Point Despite Ongoing Stock Market Weakness
LifeStance Stock is flirting with its latest buy point amid the ongoing stock market weakness. Its RS line hit a new high last week.
LF
NASDAQ · LFST
LifeStance Health Group, Inc.
Healthcare · Medical - Care Facilities
$13.37
Up+$0.67 (+4.97%)
Updated Nov 4, 2026, 5:32 PM
SID Score
6.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.63B
- P/E ratio
- -287.34
- Dividend yield
- 0.00%
- 52-week range
- $5.98 – $13.76
- Volume
- 3.03M
- Avg. volume
- 1.9M
Price performance · LFST
LFST price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
LFST closed at $13.37 after 21 trading sessions, up 10.31% for the selected period.
- Last close
- $13.37
- Period change
- +10.31%
- Period low
- $11.74
- Period high
- $13.64
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $13.29 | $13.69 | $13.28 | $13.37 | 3.03M |
| Nov 2, 2026 | $13.50 | $13.60 | $13.175 | $13.26 | 3.36M |
| Oct 30, 2026 | $13.64 | $13.76 | $13.265 | $13.40 | 2.3M |
| Oct 29, 2026 | $13.46 | $13.65 | $13.32 | $13.635 | 2.47M |
| Oct 28, 2026 | $13.05 | $13.625 | $13.05 | $13.39 | 4.27M |
| Oct 27, 2026 | $13.12 | $13.25 | $12.94 | $13.10 | 3.16M |
| Oct 26, 2026 | $12.93 | $13.195 | $12.82 | $13.06 | 3.52M |
| Oct 23, 2026 | $12.55 | $12.95 | $12.415 | $12.93 | 2.98M |
| Oct 22, 2026 | $12.30 | $12.63 | $12.17 | $12.56 | 4.16M |
| Oct 21, 2026 | $12.13 | $12.40 | $12.01 | $12.33 | 3.55M |
| Oct 20, 2026 | $11.94 | $12.32 | $11.81 | $12.22 | 1.96M |
| Oct 19, 2026 | $11.74 | $11.92 | $11.69 | $11.77 | 3.65M |
| Oct 16, 2026 | $12.45 | $12.49 | $11.68 | $11.74 | 2.82M |
| Oct 15, 2026 | $12.53 | $12.6155 | $12.32 | $12.37 | 3.54M |
| Oct 14, 2026 | $12.20 | $12.53 | $12.1609 | $12.52 | 3.44M |
| Oct 13, 2026 | $12.51 | $12.68 | $12.29 | $12.32 | 1.86M |
| Oct 12, 2026 | $12.45 | $12.54 | $12.38 | $12.48 | 2.19M |
| Oct 9, 2026 | $12.04 | $12.46 | $12.03 | $12.42 | 1.8M |
| Oct 8, 2026 | $12.02 | $12.16 | $11.855 | $12.06 | 2.36M |
| Oct 7, 2026 | $11.99 | $12.295 | $11.96 | $12.11 | 3.65M |
| Oct 6, 2026 | $12.20 | $12.32 | $11.92 | $12.12 | 2.5M |
Latest LFST news
The latest Smart Investors Daily articles mentioning LFST.
Stock researchCompany · Overview
Company
Market Activity
Research & News
LFST research
Overview
Company profile and research snapshot.
Company profile
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $8.00
- Implied upside
- —
- Analysts
- 15
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 5, 2026 | Keybanc | Overweight | — |
| Sep 10, 2026 | Barclays | Overweight | — |
| Sep 9, 2026 | Canaccord Genuity | Buy | — |
| Aug 19, 2026 | BTIG | Buy | — |
| Aug 14, 2026 | JP Morgan | Neutral | — |
News briefing
Generated Nov 4, 2026, 5:20 PM
Why Is LFST Up Today?
LifeStance Health Group shares gained 4.41% today, outperforming amid broader market weakness and approaching a technical buy point that has caught investors' attention. The telehealth mental health provider is drawing renewed interest from value-oriented investors despite challenging market conditions affecting growth stocks.
Bottom line: LifeStance Health's 4.41% gain reflects technical strength and renewed analyst attention on its profitability, positioning it as a potential play for those seeking exposure to the growing mental health services market. Investors should monitor whether the company can maintain momentum through market weakness and sustain profitability while competing in an increasingly crowded telehealth space, while watching for a broader market inflection that could validate or invalidate the current technical setup.
Yahoo · Nov 2, 2026
1 profitable stock to research further and 2 we ignore
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Yahoo · Oct 29, 2026
/C O R R E C T I O N - LifeStance Health/
LifeStance Health, one of the nation's largest providers of outpatient mental healthcare, is expanding access to two specialty services for treatment-resistant depression – esketamine1 (Spravato) and transcranial magnetic stimulation2 (TMS) – as separate analyses show meaningful reductions in depression symptoms and suicidal ideation among patients receiving each treatment.
Yahoo · Oct 29, 2026
Teladoc Soars 11% on Q3 Beat and Raised Outlook as “Insurance Revenue Exceeded Our Expectations”
Key TakeawaysTeladoc Health rose 11% after its third-quarter adjusted EBITDA beat guidance, rising 14% to $79. 4 million.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
